Chronic hepatitis B treatment initiation and modification patterns in five European countries: A 2-year longitudinal, non-interventional study

Antiviral Therapy

Volumn 19, Issue 3, 2014, Pages 235-243

  Marcellin, Patrick ^a   Arama, Victoria ^b,c   Leblebicioglu, Hakan ^d   Zarski, Jean Pierre ^e   Zeuzem, Stefan ^f   Mauss, Stefan ^g   Sieklucki, Jerzy ^h   Acalovschi, Monica ⁱ   Usluer, Gaye ^j   Klauck, Isabelle ^k   Morais, Edith ^k   Bjork, Stefan ^l   Lescrauwaet, Benedicte ^m   Kamar, Driss ⁿ   Simon, Krzysztof ^o   Botta Fridlund, Danielle ^p   Pol, Stanislas ^p   Maynard, Marianne ^p   Habersetzer, François ^p   Causse, Xavier ^p   Alric, Laurent ^p   Noumbissie, Pauline Simo ^p   Gerken, Guido ^p   Goeser, Tobias ^p   Niederau, Claus ^p   Wiese, Manfred ^p   Busch, Heiner ^p   Schneider, Lothar ^p   Schubert, Jens ^p   Brenner, Meike ^p   Scheffrahn, Inka ^p   Vermehren, Johannes ^p   Bludzin, Wieslawa ^p   Dziambor, Andrzej ^p   Goryszewski, Dariusz ^p   Postawa Klosinska, Barbara ^p   Pleśniak, Robert ^p   Tanasescu, Coman ^p   Raducan, Lucian ^p   Sporea, Ioan ^p   Jinga, Mariana ^p   Voiculescu, Mihai ^p   Chira, Olimpia ^p   Arama, Sorin Stefan ^p   Radulescu, Mihaela Andreea ^p   Nicolau, Adriana ^p   Nitescu, Doina ^p   Nanu, Andrei ^p   Dan, Isabel ^p   Nicolita, Diana ^p   Ionescu, Camelia ^p   Ecobici, Monica ^p   Micu, Gina ^p   Parepa, Raluca Irinel ^p   Suceveanu, Andra ^p   Baskol, Mevlut ^p   Ozaras, Resat ^p   Ulusoy, Sercan ^p   Esen, Saban ^p   Kartal, Elif Doyuk ^p   Yamazhan, Tansu ^p   more..

^a BEAUJON HOSPITAL   (France)

^b CAROL DAVILA UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^c Prof Dr Matei Bals National Institute of Infectious Diseases   (Romania)

^d ONDOKUZ MAYIS UNIVERSITY   (Turkey)

^e GRENOBLE UNIVERSITY HOSPITAL   (France)

^f UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^g Center for HIV and Hepatogastroenterology   (Germany)

^h Private Medical Center   (Poland)

ⁱ IULIU HATIEGANU UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^j ESKISEHIR OSMANGAZI UNIVERSITY   (Turkey)

^k BRISTOL MYERS SQUIBB   (United States)

^l Institute of Applied Economics and Health Research   (Denmark)

^m Xintera Consulting Bvba   (Belgium)

ⁿ DOCS International   (France)

^o WROCLAW MEDICAL UNIVERSITY   (Poland)

^p NONE

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADEFOVIR; ALANINE AMINOTRANSFERASE; ALPHA2A INTERFERON; ENTECAVIR; LAMIVUDINE; PEGINTERFERON ALPHA2A; PEGINTERFERON ALPHA2B; TELBIVUDINE; TENOFOVIR; VIRUS DNA; ADENINE; ALPHA INTERFERON; ANTIVIRUS AGENT; GUANINE; HEPATITIS B(E) ANTIGEN; MACROGOL DERIVATIVE; PHOSPHONIC ACID DERIVATIVE; RECOMBINANT PROTEIN;

ADULT; AGED; ANTIVIRAL THERAPY; ARTICLE; CONTROLLED STUDY; DRUG MONITORING; FEMALE; FRANCE; GERMANY; HEPATITIS B; HUMAN; INFECTION CONTROL; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; POLAND; PRIORITY JOURNAL; PROBABILITY; PROSPECTIVE STUDY; ROMANIA; TURKEY (REPUBLIC); ADOLESCENT; ANALOGS AND DERIVATIVES; BLOOD; DISEASE MANAGEMENT; DRUG EFFECTS; EUROPE; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; MIDDLE AGED; PHYSIOLOGY; VERY ELDERLY; VIROLOGY;

ADENINE; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ALANINE TRANSAMINASE; ANTIVIRAL AGENTS; DISEASE MANAGEMENT; DNA, VIRAL; EUROPE; FEMALE; GUANINE; HEPATITIS B E ANTIGENS; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; INTERFERON-ALPHA; LAMIVUDINE; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; ORGANOPHOSPHONATES; POLYETHYLENE GLYCOLS; PROSPECTIVE STUDIES; RECOMBINANT PROTEINS;

EID: 84902652433     PISSN: 13596535     EISSN: 20402058     Source Type: Journal    
DOI: 10.3851/IMP2573     Document Type: Article

References (15)

1. Hatzakis A, Wait S, Bruix J, et al. The state of hepatitis B and C in Europe: report from the hepatitis B and C summit conference*. J Viral Hepat 2011; 18 Suppl 1:1-16.
2. Chung NS, Kwon OS, Park CH, et al. [A comparative cross-sectional study of the development of hepatocellular carcinoma in patients with liver cirrhosis caused by hepatitis B virus, alcohol, or combination of hepatitis B virus and alcohol]. Korean J Gastroenterol 2007; 49:369-375. Korean.
3. Yim HJ, Lok AS. Natural history of chronic hepatitis B virus infection: what we knew in 1981 and what we know in 2005. Hepatology 2006; 43:S173-S181.
4. McMahon BJ. Epidemiology and natural history of hepatitis B. Semin Liver Dis 2005; 25 Suppl 1:3-8.
5. Lok AS, McMahon BJ. Chronic hepatitis B: update 2009. Hepatology 2009; 50:661-662.
6. European Association For The Study Of The Liver. EASL Clinical Practice Guidelines: management of chronic hepatitis B virus infection. J Hepatol 2012; 57:167-185.
7. Chen CJ, Yang HI. Natural history of chronic hepatitis B REVEALed. J Gastroenterol Hepatol 2011; 26:628-638.
8. Chang TT, Liaw YF, Wu SS, et al. Long-term entecavir therapy results in the reversal of fibrosis/cirrhosis and continued histological improvement in patients with chronic hepatitis B. Hepatology 2010; 52:886-893.
9. Yuen MF, Wong DK, Sum SS, et al. Effect of lamivudine therapy on the serum covalently closed-circular (ccc) DNA of chronic hepatitis B infection. Am J Gastroenterol 2005; 100:1099-1103.
10. Dienstag JL, Goldin RD, Heathcote EJ, et al. Histological outcome during long-term lamivudine therapy. Gastroenterology 2003; 124:105-117.
11. Marcellin P, Chang TT, Lim SG, et al. Long-term efficacy and safety of adefovir dipivoxil for the treatment of hepatitis B e antigen-positive chronic hepatitis B. Hepatology 2008; 48:750-758.
12. Hadziyannis SJ, Tassopoulos NC, Heathcote EJ, et al. Longterm therapy with adefovir dipivoxil for HBeAg-negative chronic hepatitis B for up to 5 years. Gastroenterology 2006; 131:1743-1751.
13. Liaw YF, Kao JH, Piratvisuth T, Chan HLY, Chien RN, Liu CJ. Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2012 update. Hepatology International 2012; 6:531-561.
14. Fattovich G, Bortolotti F, Donato F. Natural history of chronic hepatitis B: special emphasis on disease progression and prognostic factors. J Hepatol 2008; 48:335-352.
15. European Association For The Study Of The Liver. EASL Clinical Practice Guidelines: management of chronic hepatitis B. J Hepatol 2009; 50:227-242.